Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study

Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study

BackgroundMajor depressive disorder (MDD) constitutes the leading cause of disability worldwide. Although efficacious antidepressant pharmacotherapies exist for MDD, only about 40–60% of the patients respond to initial treatment. However, there is still a lack of robustly established and applicable...

Full description

Bibliographic Details
Main Authors: Agorastos Agorastos, Anne Sommer, Alexandra Heinig, Klaus Wiedemann, Cüneyt Demiralay
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Psychiatry
Subjects:
copeptin
vasopressin (AVP)
depression
hypothalamus-pituitary-adrenal axis (HPA axis)
cortisol
biomarker
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00453/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2020.00453/full

Similar Items